Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Redcare Pharmacy (DE:RDC)
XETRA:RDC
Redcare Pharmacy (RDC) Stock Price & Analysis
19 Followers
RDC Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€93.22 - €153.00
Previous Close€114.8
Volume138.21K
Average Volume (3M)85.53K
Market Cap
€2.20B
Enterprise Value€2.27B
Total Cash (Recent Filing)€184.00M
Total Debt (Recent Filing)€255.19M
Price to Earnings (P/E)―
Beta1.58
Next Earnings
Jul 30, 2024EPS Estimate
-€0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.50
Shares Outstanding18,199,281
10 Day Avg. Volume49,034
30 Day Avg. Volume85,532
Standard Deviation0.17
R-Squared0.02
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€153.89Price Target Upside18.97% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
Redcare Pharmacy News
Bulls Say, Bears Say
Bulls Say
Market OpportunityCurrent share price levels do not reflect the significant eRx growth opportunity and offer an attractive entry level, in analyst's view.
Product LaunchThe upcoming launch of Redcare's NFC solution aims to tap into the substantial German electronic prescription market.
Sales GrowthGroup sales of €560m were up 18.6% year over year excluding Mediserve.
Bears Say
EarningsGroup sales sit 2% below company-compiled consensus.
Financial PerformanceFree cash flow continues to be positive at €19.3m but sits below 1Q23 of €35.4m.
Operational PerformanceTotal prescription sales at €156m were 6% below consensus mainly due to ramp-up effects from the transition to electronic prescriptions.
---
Options Prices
Currently, No data available
---
Ownership Overview
6.35% Insiders
9.65% Mutual Funds
3.93% Other Institutional Investors
80.08% Public Companies and
Individual Investors
RDC FAQ
What was Redcare Pharmacy’s price range in the past 12 months?
Redcare Pharmacy lowest stock price was €93.22 and its highest was €153.00 in the past 12 months.
What is Redcare Pharmacy’s market cap?
Currently, no data Available
When is Redcare Pharmacy’s upcoming earnings report date?
Redcare Pharmacy’s upcoming earnings report date is Jul 30, 2024 which is in 25 days.
How were Redcare Pharmacy’s earnings last quarter?
Redcare Pharmacy released its earnings results on Apr 25, 2024. The company reported -€0.223 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.223.
Is Redcare Pharmacy overvalued?
According to Wall Street analysts Redcare Pharmacy’s price is currently Undervalued.
Does Redcare Pharmacy pay dividends?
Redcare Pharmacy does not currently pay dividends.
What is Redcare Pharmacy’s EPS estimate?
Redcare Pharmacy’s EPS estimate is -€0.08.
How many shares outstanding does Redcare Pharmacy have?
Redcare Pharmacy has 20,342,485 shares outstanding.
What happened to Redcare Pharmacy’s price movement after its last earnings report?
Redcare Pharmacy reported an EPS of -€0.223 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.917%.
Which hedge fund is a major shareholder of Redcare Pharmacy?
Currently, no hedge funds are holding shares in DE:RDC
---
Redcare Pharmacy Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€153.89 (18.97% Upside)
€153.89 (18.97% Upside)
Insider Transactions
Bought Shares
Worth €49.9K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
18.27%
12-Months-Change
Fundamentals
Return on Equity
-2.23%
Trailing 12-Months
Asset Growth
33.32%
Trailing 12-Months
Company Description
Redcare Pharmacy
Shop Apotheke Europe NV operates an online pharmacy store. Its product portfolio is focused on non-prescription medications, over-the-counter medications, and pharmacy-related beauty and personal care products. The company's operating segment includes DACH and International. It generates maximum revenue from the DACH segment. Geographically, it has a presence in Germany, Belgium, Spain, France, and Italy.
---
RDC Stock 12 Month Forecast
Average Price Target
€153.89
▲(18.97% Upside)
Technical Analysis
Best Analysts Covering RDC
1 Year
1 Year Success Rate
20/25 ratings generated profit
1 Year Average Return
+79.83%
reiterated a buy rating yesterday
Copying Christian Salis's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +79.83% per trade.
---